S
SABS//CIK 0001833214
SAB Biotherapeutics, Inc.
Market Data
$4.10−$0.18 (−4.21%)
SABS · Last trade
Prev Close
$4.28
Range (30d)
$3.57 – $4.45
Recent Filings
- 8-K14.1 MBSAB Biotherapeutics, Inc.Jan 12, 4:47 PM ET·0001193125-26-010515
- 8-K268.6 KBSAB Biotherapeutics, Inc.Jan 7, 8:30 AM ET·0001193125-26-005487
- 8-K190.8 KBSAB Biotherapeutics, Inc.Dec 29, 4:00 PM ET·0001193125-25-335267
- 10-Q16.2 MBSAB Biotherapeutics, Inc.Nov 13, 5:43 PM ET·0001193125-25-280572
- 8-K187.9 KBSAB Biotherapeutics, Inc.Sep 30, 4:35 PM ET·0001193125-25-225119
- 8-K495.6 KBSAB Biotherapeutics, Inc.Sep 26, 4:45 PM ET·0001193125-25-220721
- 10-Q13.2 MBSAB Biotherapeutics, Inc.Aug 7, 7:30 AM ET·0000950170-25-104566
- 8-K1.7 MBSAB Biotherapeutics, Inc.Jul 21, 7:31 AM ET·0000950170-25-097078
- 8-K209.2 KBSAB Biotherapeutics, Inc.Jul 17, 5:00 PM ET·0000950170-25-096645
- 10-Q11.4 MBSAB Biotherapeutics, Inc.May 9, 8:42 AM ET·0000950170-25-067554
Insiders
10- Bausch Christoph LawrenceCHIEF OPERATING OFFICER
- Beyer Russell PChief Financial Officer
- Big Cypress Holdings LLCDirector, CEO and CFO, 10% Owner
- Carillo Carlos NSVP Regulatory Affairs
- Collins Stephen D.Director
- Conley Mark WilliamSee Remarks
- Ellias Helen K.Director
- Erickson Bruce KippChief Operating Officer
- Finnegan FrederickChief Business Officer
- Giberson ScottDirector
Tickers
Addresses
business
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
mailing
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
Former Names
- Big Cypress Acquisition Corp.2021-10-22